Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 77

1.

Effect on apoptosis and cell cycle of recombinant double negative dominant mutation Survivin (T34/117A) in breast cancer cell B-Cap-37.

Wang L, Kang Y, Zheng W, Li L, Shi L, Ma X.

Biomed Pharmacother. 2014 Apr;68(3):277-84. doi: 10.1016/j.biopha.2013.11.001. Epub 2013 Nov 25.

PMID:
24513056
2.

[Preparation of recombinant HIV-TATm-survivin (T34A) protein and its pro-apoptosis activity to cancer cells in vitro].

Zheng WY, Ma XY, Wei DZ, Wang JZ, Liu QH, Ma YS, Yang SL.

Sheng Wu Gong Cheng Xue Bao. 2006 Mar;22(2):285-92. Chinese.

PMID:
16607958
3.

High-level expression, purification and pro-apoptosis activity of HIV-TAT-survivin (T34A) mutant to cancer cells in vitro.

Ma X, Zheng W, Wei D, Ma Y, Wang T, Wang J, Liu Q, Yang S.

J Biotechnol. 2006 May 29;123(3):367-78. Epub 2006 Jan 10.

PMID:
16406157
4.

Construction, expression, and purification of HIV-TAT-survivin (T34A) mutant: a pro-apoptosis protein in Escherichia coli.

Ma X, Zheng W, Wei D, Ma Y, Wang T, Wang J, Liu Q, Yang S.

Protein Expr Purif. 2006 May;47(1):36-44. Epub 2005 Oct 11.

PMID:
16260148
5.

Aurora B confers cancer cell resistance to TRAIL-induced apoptosis via phosphorylation of survivin.

Yoon MJ, Park SS, Kang YJ, Kim IY, Lee JA, Lee JS, Kim EG, Lee CW, Choi KS.

Carcinogenesis. 2012 Mar;33(3):492-500. doi: 10.1093/carcin/bgr298. Epub 2011 Dec 9.

PMID:
22159225
6.

Multisite mutation of monomer survivin with enhanced effect on apoptosis regulation of breast cancer cells.

Dai G, Zheng W, Ma X, Wang P.

Biomed Pharmacother. 2015 Feb;69:111-8. doi: 10.1016/j.biopha.2014.11.015. Epub 2014 Nov 28.

PMID:
25661346
7.

Huaier aqueous extract inhibits proliferation of breast cancer cells by inducing apoptosis.

Zhang N, Kong X, Yan S, Yuan C, Yang Q.

Cancer Sci. 2010 Nov;101(11):2375-83. doi: 10.1111/j.1349-7006.2010.01680.x.

8.

Roles of BIM induction and survivin downregulation in lapatinib-induced apoptosis in breast cancer cells with HER2 amplification.

Tanizaki J, Okamoto I, Fumita S, Okamoto W, Nishio K, Nakagawa K.

Oncogene. 2011 Sep 29;30(39):4097-106. doi: 10.1038/onc.2011.111. Epub 2011 Apr 18.

PMID:
21499301
9.
10.

3,3',4', 5'-Tetramethoxychalcone inhibits human oral cancer cell proliferation and migration via p53-mediated mitochondrial-dependent apoptosis.

Lai CK, Rao YK, Chang KR, Lin CW, Su HL, Chang CS, Lai CH, Tzeng YM.

Anticancer Res. 2014 Apr;34(4):1811-9.

PMID:
24692714
11.

Cephalochromin induces G0/G1 cell cycle arrest and apoptosis in A549 human non-small-cell lung cancer cells by inflicting mitochondrial disruption.

Hsiao CJ, Hsiao G, Chen WL, Wang SW, Chiang CP, Liu LY, Guh JH, Lee TH, Chung CL.

J Nat Prod. 2014 Apr 25;77(4):758-65. doi: 10.1021/np400517g. Epub 2014 Mar 3.

PMID:
24588135
12.
14.

Antitumor activity of a novel survivin siRNA.

Li Y, Li Y, Lee RJ, Wang X, Du L, Zhao L, Liu Y, Teng L.

Pak J Pharm Sci. 2015 Sep;28(5 Suppl):1887-90.

PMID:
26525031
15.

Anti-tumor potential of 15,16-dihydrotanshinone I against breast adenocarcinoma through inducing G1 arrest and apoptosis.

Tsai SL, Suk FM, Wang CI, Liu DZ, Hou WC, Lin PJ, Hung LF, Liang YC.

Biochem Pharmacol. 2007 Dec 3;74(11):1575-86. Epub 2007 Aug 11.

PMID:
17869226
16.

Therapeutic targeting of the survivin pathway in cancer: initiation of mitochondrial apoptosis and suppression of tumor-associated angiogenesis.

Blanc-Brude OP, Mesri M, Wall NR, Plescia J, Dohi T, Altieri DC.

Clin Cancer Res. 2003 Jul;9(7):2683-92.

17.

Antisense inhibition of survivin expression as a cancer therapeutic.

Carrasco RA, Stamm NB, Marcusson E, Sandusky G, Iversen P, Patel BK.

Mol Cancer Ther. 2011 Feb;10(2):221-32. doi: 10.1158/1535-7163.MCT-10-0756. Epub 2011 Jan 7.

18.

Apoptotic death in curcumin-treated NPC-TW 076 human nasopharyngeal carcinoma cells is mediated through the ROS, mitochondrial depolarization and caspase-3-dependent signaling responses.

Kuo CL, Wu SY, Ip SW, Wu PP, Yu CS, Yang JS, Chen PY, Wu SH, Chung JG.

Int J Oncol. 2011 Aug;39(2):319-28. doi: 10.3892/ijo.2011.1057. Epub 2011 May 26.

PMID:
21617861
19.
20.

A novel anticancer agent, SKLB70359, inhibits human hepatic carcinoma cells proliferation via G0/G1 cell cycle arrest and apoptosis induction.

Dai XY, Zeng XX, Peng F, Han YY, Lin HJ, Xu YZ, Zhou T, Xie G, Deng Y, Mao YQ, Yu LT, Yang L, Zhao YL.

Cell Physiol Biochem. 2012;29(1-2):281-90. doi: 10.1159/000337609. Epub 2012 Mar 1.

Supplemental Content

Support Center